Company Profile

# ACME GROUP BEGAN ITS JOURNEY IN 2005 WITH A MISSION OF BECOMING A LEADER IN THE CONTRACT MANUFACTURING SPACE AND A PREFERRED BUSINESS PARTNER FOR PHARMACEUTICAL COMPANIES LOOKING FOR WORLD-CLASS CAPABILITIES AND SCALABLE OPERATIONS. OVER THE YEARS, WE HAVE SCALED NEW HEIGHTS IN THE PHARMACEUTICAL VALUE CHAIN AND TODAY PROVIDES FULLY INTEGRATED CONTRACT MANUFACTURING, DEVELOPMENT AND LICENSING SOLUTION TO SOME OF THE TOP INDIAN AND GLOBAL PHARMACEUTICAL COMPANIES. ACME IS COMMITTED TO FAST GROWTH, INNOVATION, AND EXCEPTIONAL SERVICE. CURRENTLY, THE GROUP CONSISTS OF THREE STATE-OF-THE-ART, FAST-GROWING COMPANIES, ACME FORMULATION, IMMACULE AND ACME GENERICS. WE ARE PRODUCING 17 BILLION TABLETS, 3 BILLION CAPSULES, 30 MILLION LIQUID VIALS/AMPOULES AND 12 MILLION LYOPHILIZED VIALS. WE HAVE ALSO EXPANDED INTO NICHE SEGMENTS OF ORAL HORMONES (FEMALE SEX HORMONES AND LEVOTHYROXINE) ALONG WITH GENERAL AND ONCOLOGY INJECTABLES- LIQUID AND LYOPHILIZED ALONG WITH OPHTHALMIC, PFS AND CARTRIDGES